Invivyd, Inc.
IVVDHealthcare|Biotechnology|US
$0.56
-0.02 (-3.76%)
DCF Value
$10.71
Tangible Book / Share
$0.57
Cash / Share
$0.50
Ownership Breakdown
88.8%
Float
294.8M
Shares Outstanding
261.7M
Float Shares
Major Holders (40)
Combined: 232.6%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | IA, HC | 12.10% | 25,383,077 | Nov 14, 2025 | 13D/G |
| Janus Henderson Biotech Innovation Master Fund Ltd | Investment company | 10.30% | 21,576,145 | Nov 14, 2025 | 13D/G |
| BVF Partners L P/Il | IA, PN | 9.99% | 29,571,826 | Aug 14, 2026 | 13D/G |
| BVF Inc/Il | Corporation | 9.99% | 29,571,826 | Aug 14, 2026 | 13D/G |
| Lampert Mark N | Individual | 9.99% | 29,571,826 | Aug 14, 2026 | 13D/G |
| BVF GP Holdings LLC | Other | 9.20% | 27,215,960 | Aug 14, 2026 | 13D/G |
| Adimab, LLC | Other | 7.30% | 20,262,170 | Dec 29, 2025 | 13D/G |
| Rajeev Shah | HC, IN | 7.00% | 21,342,442 | May 15, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 7.00% | 21,342,442 | May 15, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 7.00% | 21,342,442 | May 15, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 7.00% | 21,342,442 | May 15, 2026 | 13D/G |
| Terrance McGuire | Individual | 6.80% | 8,094,512 | Dec 12, 2024 | 13D/G |
| Maverick Capital, Ltd. | Investment adviser | 6.70% | 18,970,913 | Feb 13, 2026 | 13D/G |
| Lee S. Ainslie III | Individual | 6.70% | 18,970,913 | Feb 13, 2026 | 13D/G |
| Maverick Capital Management, LLC | Holding company | 6.70% | 18,970,913 | Feb 13, 2026 | 13D/G |
| Perceptive Advisors LLC | Investment adviser | 6.30% | 18,490,636 | Aug 14, 2026 | 13D/G |
| Perceptive Life Sciences Master Fund, Ltd. | Corporation | 6.30% | 18,490,636 | Aug 14, 2026 | 13D/G |
| Joseph Edelman | Individual | 6.30% | 18,490,636 | Aug 14, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.50% | 16,124,696 | Jul 28, 2026 | 13D/G |
| Biotechnology Value Fund L P | Partnership | 5.40% | 16,031,969 | Aug 14, 2026 | 13D/G |
| BVF I GP LLC | Other | 5.40% | 16,031,969 | Aug 14, 2026 | 13D/G |
| Mithril II GP LP | Partnership | 4.80% | 11,241,580 | Nov 12, 2025 | 13D/G |
| Ajay Royan | Individual | 4.80% | 11,241,580 | Nov 12, 2025 | 13D/G |
| Peter Thiel | Individual | 4.80% | 11,241,580 | Nov 12, 2025 | 13D/G |
| Mithril II LP | Partnership | 4.80% | 11,241,580 | Nov 12, 2025 | 13D/G |
| Mithril II UGP LLC | Other | 4.80% | 11,241,580 | Nov 12, 2025 | 13D/G |
| Abigail P. Johnson | Individual | 4.80% | 5,775,549 | Feb 12, 2025 | 13D/G |
| FMR LLC | Holding company | 4.80% | 5,775,549 | Feb 12, 2025 | 13D/G |
| Marc Elia | HC, IN | 4.60% | 9,548,250 | Aug 26, 2025 | 13D/G |
| M28 Capital Management LP | IA, PN | 4.40% | 9,248,250 | Aug 26, 2025 | 13D/G |
| Biotechnology Value Fund II LP | Partnership | 3.80% | 11,183,991 | Aug 14, 2026 | 13D/G |
| BVF II GP LLC | Other | 3.80% | 11,183,991 | Aug 14, 2026 | 13D/G |
| Polaris Partners IX, L.P. | Partnership | 3.50% | 4,202,679 | Dec 12, 2024 | 13D/G |
| Polaris Partners GP IX, L.L.C. | Other | 3.50% | 4,202,679 | Dec 12, 2024 | 13D/G |
| Guy Levy | Individual | 2.80% | 7,708,727 | Feb 12, 2026 | 13D/G |
| Soleus GP, LLC | Other | 2.80% | 7,708,727 | Feb 12, 2026 | 13D/G |
| Soleus Capital Management, L.P. | Partnership | 2.80% | 7,708,727 | Feb 12, 2026 | 13D/G |
| Polaris Venture Management Co. V, L.L.C. | Other | 2.70% | 3,233,580 | Dec 12, 2024 | 13D/G |
| Jonathan Flint | Individual | 2.70% | 3,233,580 | Dec 12, 2024 | 13D/G |
| Polaris Venture Partners V, L.P. | Partnership | 2.60% | 3,120,194 | Dec 12, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 16,816,876 acquired · 1,594,196 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sheffield Ian | director | Aug 31, 2026 | AWARD | 100,000 | $0.95 | $95.5K | Form 4 |
| Sheffield Ian | Aug 30, 2026 | OTHER | 0 | — | — | Form 4 | |
| Elia Marc | director, officer: Chief Executive Officer | Aug 30, 2026 | AWARD | 10,700,000 | $0.96 | $10.3M | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Aug 17, 2026 | SELL | 22,355 | $0.72 | $16.1K | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Aug 18, 2026 | SELL | 18,425 | $0.84 | $15.5K | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 17, 2026 | SELL | 22,355 | $0.72 | $16.1K | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 18, 2026 | SELL | 18,425 | $0.84 | $15.5K | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 17, 2026 | SELL | 22,355 | $0.72 | $16.1K | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 18, 2026 | SELL | 18,425 | $0.84 | $15.5K | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 15, 2026 | OPTION EX. | 170,000 | — | — | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 17, 2026 | SELL | 37,256 | $0.72 | $26.9K | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 18, 2026 | SELL | 30,706 | $0.84 | $25.9K | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 15, 2026 | OPTION EX. | 170,000 | — | — | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 17, 2026 | SELL | 20,679 | $0.72 | $14.9K | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 18, 2026 | SELL | 17,043 | $0.84 | $14.4K | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 15, 2026 | OPTION EX. | 102,000 | — | — | Form 4 |
| Mina Michael | CMO and Chief Epidemiologist | Jul 31, 2026 | AWARD | 1,125,000 | $0.54 | $601.9K | Form 4 |
| Mina Michael | CMO and Chief Epidemiologist | Jul 31, 2026 | OTHER | 375,000 | $1.33 | $498.8K | Form 4 |
| Royan Ajay | director | May 19, 2026 | AWARD | 50,000 | $1.04 | $52.0K | Form 4 |
| MCLAUGHLIN KEVIN F | director | May 19, 2026 | AWARD | 50,000 | $1.04 | $52.0K | Form 4 |
| MCGUIRE TERRANCE | director | May 19, 2026 | AWARD | 50,000 | $1.04 | $52.0K | Form 4 |
| Elia Marc | director, other: See Remarks | May 19, 2026 | AWARD | 50,000 | $1.04 | $52.0K | Form 4 |
| BOLNO PAUL | director | May 19, 2026 | AWARD | 32,876 | $1.04 | $34.2K | Form 4 |
| Berry Tamsin | director | May 19, 2026 | AWARD | 50,000 | $1.04 | $52.0K | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Feb 17, 2026 | SELL | 18,189 | $1.54 | $28.0K | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Feb 18, 2026 | SELL | 19,392 | $1.58 | $30.6K | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Green Julie | Chief Human Resources Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Green Julie | Chief Human Resources Officer | Feb 17, 2026 | SELL | 19,663 | $1.54 | $30.3K | Form 4 |
| Green Julie | Chief Human Resources Officer | Feb 18, 2026 | SELL | 20,964 | $1.58 | $33.1K | Form 4 |
| Green Julie | Chief Human Resources Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Feb 17, 2026 | SELL | 19,663 | $1.54 | $30.3K | Form 4 |
| Duke William E. | Chief Financial Officer | Feb 18, 2026 | SELL | 20,964 | $1.58 | $33.1K | Form 4 |
| Duke William E. | Chief Financial Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Feb 17, 2026 | SELL | 19,663 | $1.54 | $30.3K | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Feb 18, 2026 | SELL | 20,964 | $1.58 | $33.1K | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Feb 15, 2026 | OPTION EX. | 99,000 | — | — | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Feb 15, 2026 | OPTION EX. | 165,000 | — | — | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Feb 17, 2026 | SELL | 32,771 | $1.54 | $50.5K | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Feb 18, 2026 | SELL | 34,939 | $1.58 | $55.1K | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Feb 15, 2026 | OPTION EX. | 165,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Jan 29, 2026 | AWARD | 625,000 | $1.85 | $1.2M | Form 4 |
| Green Julie | Chief Human Resources Officer | Jan 29, 2026 | AWARD | 675,000 | $1.85 | $1.2M | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Jan 29, 2026 | AWARD | 675,000 | $1.85 | $1.2M | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Jan 29, 2026 | AWARD | 820,000 | $1.85 | $1.5M | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Jan 29, 2026 | AWARD | 625,000 | $1.85 | $1.2M | Form 4 |
| MCLAUGHLIN KEVIN F | director | Nov 19, 2025 | BUY | 50,000 | $2.50 | $125.0K | Form 4 |
| BOLNO PAUL | director | Sep 22, 2025 | AWARD | 100,000 | $1.22 | $122.0K | Form 4 |
| BOLNO PAUL | Sep 22, 2025 | OTHER | 0 | — | — | Form 4 | |
| Lee Timothy Edward | Chief Commercial Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Aug 18, 2025 | SELL | 20,013 | $0.65 | $13.0K | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Aug 19, 2025 | SELL | 29,643 | $0.57 | $16.8K | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 18, 2025 | SELL | 20,013 | $0.65 | $13.0K | Form 4 |
| Duke William E. | Chief Financial Officer | Aug 19, 2025 | SELL | 29,643 | $0.57 | $16.8K | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 18, 2025 | SELL | 20,013 | $0.65 | $13.0K | Form 4 |
| Green Julie | Chief Human Resources Officer | Aug 19, 2025 | SELL | 29,643 | $0.57 | $16.8K | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 15, 2025 | OPTION EX. | 165,000 | — | — | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 15, 2025 | OPTION EX. | 165,000 | — | — | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 18, 2025 | SELL | 33,352 | $0.65 | $21.7K | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Aug 19, 2025 | SELL | 49,402 | $0.57 | $28.0K | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 15, 2025 | OPTION EX. | 99,000 | — | — | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 18, 2025 | SELL | 18,512 | $0.65 | $12.0K | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Aug 19, 2025 | SELL | 27,420 | $0.57 | $15.5K | Form 4 |
| MCGUIRE TERRANCE | director | May 20, 2025 | AWARD | 50,000 | $0.81 | $40.5K | Form 4 |
| Berry Tamsin | director | May 20, 2025 | AWARD | 50,000 | $0.81 | $40.5K | Form 4 |
| MCLAUGHLIN KEVIN F | director | May 20, 2025 | AWARD | 50,000 | $0.81 | $40.5K | Form 4 |
| Elia Marc | director, other: See Remarks | May 20, 2025 | AWARD | 50,000 | $0.81 | $40.5K | Form 4 |
| Lindenboom Christine | director | May 20, 2025 | AWARD | 50,000 | $0.81 | $40.5K | Form 4 |
| Royan Ajay | director | May 20, 2025 | AWARD | 8,219 | $0.81 | $6.7K | Form 4 |
| Royan Ajay | director | Mar 24, 2025 | AWARD | 100,000 | $0.72 | $72.4K | Form 4 |
| Royan Ajay | director | Mar 22, 2025 | OTHER | 0 | — | — | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Feb 15, 2025 | AWARD | 950,000 | $1.61 | $1.5M | Form 4 |
| Andersen Jill | Chief Legal Officer, Secretary | Feb 15, 2025 | AWARD | 500,000 | — | — | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Feb 15, 2025 | AWARD | 950,000 | $1.61 | $1.5M | Form 4 |
| Duke William E. | Chief Financial Officer | Feb 15, 2025 | AWARD | 950,000 | $1.61 | $1.5M | Form 4 |
| Allen Robert D. III | Chief Scientific Officer | Feb 15, 2025 | AWARD | 300,000 | — | — | Form 4 |
| Duke William E. | Chief Financial Officer | Feb 15, 2025 | AWARD | 300,000 | — | — | Form 4 |
| Green Julie | Chief Human Resources Officer | Feb 15, 2025 | AWARD | 950,000 | $1.61 | $1.5M | Form 4 |
| Green Julie | Chief Human Resources Officer | Feb 15, 2025 | AWARD | 300,000 | — | — | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Feb 15, 2025 | AWARD | 950,000 | $1.61 | $1.5M | Form 4 |
| Lee Timothy Edward | Chief Commercial Officer | Feb 15, 2025 | AWARD | 300,000 | — | — | Form 4 |
| MCGUIRE TERRANCE | director | Dec 27, 2024 | SELL | 83,744 | $0.52 | $43.6K | Form 4 |
| MCGUIRE TERRANCE | director | Dec 30, 2024 | SELL | 86,545 | $0.48 | $41.8K | Form 4 |
| MCGUIRE TERRANCE | director | Dec 31, 2024 | SELL | 103,474 | $0.45 | $46.1K | Form 4 |